SIGN UP
LOG IN
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·06/20/2025 12:09:39
Listen to the news
Gainers
- Firefly Neuroscience (NASDAQ:AIFF) stock rose 19.6% to $3.59 during Friday's pre-market session. The company's market cap stands at $38.5 million.
- Quantum BioPharma (NASDAQ:QNTM) stock moved upwards by 18.45% to $35.75. The market value of their outstanding shares is at $87.7 million.
- Processa Pharmaceuticals (NASDAQ:PCSA) shares moved upwards by 17.97% to $0.29. The market value of their outstanding shares is at $2.8 million.
- Vivos Therapeutics (NASDAQ:VVOS) stock moved upwards by 12.09% to $2.78. The market value of their outstanding shares is at $14.6 million.
- Semler Scientific (NASDAQ:SMLR) shares moved upwards by 11.87% to $35.73. The company's market cap stands at $419.7 million.
- Galmed Pharmaceuticals (NASDAQ:GLMD) shares increased by 11.79% to $1.99. The market value of their outstanding shares is at $4.0 million.
Losers
- Regencell Bioscience (NASDAQ:RGC) shares declined by 18.4% to $51.7 during Friday's pre-market session. The market value of their outstanding shares is at $824.3 million.
- Terns Pharma (NASDAQ:TERN) shares decreased by 16.75% to $3.33. The market value of their outstanding shares is at $349.3 million.
- Aptevo Therapeutics (NASDAQ:APVO) shares declined by 14.24% to $4.4. The company's market cap stands at $3.4 million.
- Co-Diagnostics (NASDAQ:CODX) stock declined by 11.66% to $0.25. The market value of their outstanding shares is at $9.4 million.
- Insight Molecular (NASDAQ:IMDX) shares decreased by 11.4% to $2.8. The company's market cap stands at $90.3 million.
- Opus Genetics (NASDAQ:IRD) shares fell 10.75% to $0.83. The market value of their outstanding shares is at $55.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.